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Neonatal innate immunity and Toll-like receptor
The innate immune response is the first line of defense against microbial 
infections. Innate immunity is made up of the surface barrier, cellular 
immunity and humoral immunity. In newborn, immunologic function 
and demands are different to adults. Neonatal innate immunity 
specifically suppresses Th1-type immune responses, and not  Th2-type 
immune responses, which are enhanced. And the impaired response 
of macrophages is associated with the defective innate immunity 
in newborn period. Toll-like receptors (TLRs) play a key roles in the 
detection of invading pathogens and in the induction of innate immune 
responses. In newborn, the expression of TLRs is age dependent, so   
preterm has low expression of TLRs. Also, there are defects in signaling 
pathways downstream of TLRs. As a consequence, the defects of TLRs 
activity cause the susceptibility to infection in the neonatal period.
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Neonatal innate immunity 
Innate immunity is a natural host defense mechanism that 
operates effectively without exposure to a microorganism or its 
antigen. This system is made up of the surface barrier (such as skin 
and mucous membrane), many cells (such as neutrophil, monocyte, 
macrophage, dendritic cell, and natural killer cell) and humoral 
factors (such as complement)
4). There are limitations of exposure to 
antigens in utero and defective adaptive immunity in the newborn 
period, newborn must rely on their innate immune system for 
protection
5).
1. Surface barrier
For the immune system of surface barrier, the mucous membrane 
and skin have tissue macrophages and dendritic cells act as the 
first-line defense mechanism against the entry of microorganism. 
When microorganism enters to the body, these cells under the 
skin first recognize pathogen and are activated for secretion of 
Introduction 
Neonatal immunity is immature. Both defective adaptive immu-
nity and innate immunity contribute to the impaired neo  natal 
host defense. Adaptive immune response is impaired at birth due 
minimal preexisting antigen exposure and due to the impaired 
functions of effector B and T cells
1). And adaptive immunity is 
slowly developing system after exposure of microorganisms. In 
contrast, innate immune response does not require immunologic 
experience to function well. And innate immunity is the critical 
first-line barrier of host defense, bridging the interval between 
exposure to the pathogen and the specific response of the adaptive 
immune system
2). Therefore, a neonate is largely dependent 
on passively acquired antibodies and defective innate immune 
responses in the defense against microorganisms
3). This review 
describes the current understanding of neonatal innate immunity 
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inflammatory cytokines and recruitment of many immune cells. 
After birth, the neonatal skin and gut are rapidly colonized with 
microbial floras. The newborn skin has protective mechanism 
including vernix caseosa and protective epithelial cells. The vernix 
caseosa consists of lysozyme, α -defensins, ubiquitin, psoriasin and 
antimicrobial free fatty acids. It can act with immune cells to kill 
the microorganisms
6). 
The gastrointestinal tract is an important immune organ. It 
could secret peptides and proteins and other host defenses. Innate 
immunity plays a central role in intestinal immune defense against 
invading pathogens. Also, It serves as a bridge to the activation of 
the adaptive immune system. Some kinds of intestinal mucosal 
surface receptors serve as the pathogen recognition receptors in the 
innate immune defense system. Secreted bactericidal peptides or de-
fensins produced by the intestinal epithelia represent another crucial 
element of innate mucosal immune defense. Mutations in pattern 
recognition receptors and dysfunction of secretory bactericidal 
peptides may impair host immune defenses leading to an invasion 
of pathogens resulting in chronic inflammation of the gut
7). 
Neo  natal intestinal immunity can be significantly modified by 
breastfeeding. Breast milk contains diverse immunological factors, 
including innate immune molecules such as the antimicrobial 
proteins and peptides, lactoferrin and lysozyme
8). 
2. Cellular immunity
Mononuclear inflammatory cells, particularly mast cells and 
tissue macrophages, play a major role in the cellular immunity of 
host defense against any microbes that break the physical barriers 
such as intact skin. Mast cells acts by releasing tumor necrosis 
factor-alpha (TNF-α ). TNF-α  recruits other innate host defense 
cells such as polymorphonuclear leukocytes (PMNs), monocytes 
and dendritic cells. Also, it can instruct dendritic cells to process 
and present microbial antigenic material to T lymphocytes. This is 
a initial step in the generation of a specific immune response
4). 
Circulating monocytes differentiate into mononuclear macro-
phages which can release of many proinflammatory cytokines. In 
the newborn period, the function and the number of monocyte and 
mononuclear macrophage are normal. In vitro studies of cord blood 
from healthy term baby have effective phagocytosis activity similar 
to adult. But the functional maturation of TLR expression on the 
immune cell is main problem for the defective immune system. 
Also, selective impairment of specific immune system existed. 
For example, interferon-gamma (IFN-γ ) production is decreased 
in the newborn period
9). Overall, neonatal cellular immune system 
expresses selective impairments in Th1-type immune response 
production and Th2-type immune response enhancement. Th1 
and Th2-type immune response derived from proliferating helper 
T cells. Proliferating helper T cells differentiate into two major 
subtypes of cells known as Th1 and Th2 cells (also known as 
type 1 and type 2 helper T cells, respectively). Th1 cells produce 
IFN-γ , interleukin (IL)-2, and tumor necrosis factor-beta (TNF-β ), 
which activate macrophages and are responsible for cell-mediated 
immunity and phagocyte-dependent protective responses. By 
contrast, Th2 cells produce IL-4, IL-5, IL-10, and IL-13, which are 
responsible for strong antibody production, eosinophil activation, 
and inhibition of several macrophage functions, thus providing 
phagocyte-independent protective responses. Th1-type immune 
system relate to the alloimmune reaction between mother and 
fetus, and major cause of fetal loss. So, during pregnancy, placenta-
derived Th2-type immune cytokines antagonize Th1-type immune 
responses, there are neonatal Th2-type immune polarization
10). 
Therefore, during the newborn period, Th1-type immune 
cytokines such as TNF, IFN-α , IFN-γ , IL-12, IL-1b are decreased. 
In contrast, Th2-type immune cytokines such as IL-6, IL-8, IL-10, 
and IL-23 increased during newborn period.
Also, macrophages from newborn are hyporesponsive to 
activation by IFN-γ . The impaired production of Th1-type 
immune cytokines and the impaired response of macrophages are 
associated to the defective innate immunity in newborn period. 
Toll like receptor 
In mammals, a key factor of the innate immune system is a family 
of TLRs. Toll receptors were originally identified in Drosophila
11) and 
not only function in determination of dorsal-ventral development 
in the fly embryo but also for antimicrobial function. In adult 
Drosophila, the Toll receptor recognize micro  organism and activate 
a signaling pathway for induction of antifungal and antibacterial 
peptides about infection. In 1997, Janeway et al. identified TLR4, 
a human homologue of Toll receptor
12). They found out that the 
activation of TLR4 leads to activation of various inflammatory 
cytokines such as nuclear factor-κ B (NF- κ B), IL-1, IL-6, and IL-
8. He first suggested the existence of a set of factors which he named 
pattern recognition receptor (PRR), were capable of detecting 
pathogen-associated molecular patterns (PAMPs). TLRs act as a 
main PRR to the various PAMPs of micro  organisms
13). If a patho-
gen enters to the body, TLR recognizes microorganism PAMPs, and 
activates the signal pathway by utilization of an adaptor protein and 
results in activation of the transcription factor NF-κ B and expression 
of inflammatory cytokine genes
14,15). As a result, various cytokines, 
chemokines and colony stimulating factors produced and these 
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Another key role is a link between detection and recognition of 
microbial pathogens and the activation of the adaptive immune 
system
16). TLRs are one kind of transmembrane receptors com-
posed of extracellular leucine-rich repeat (LRR) motifs and a 
cytoplasmic Toll/interleukin-1 receptor (TIR) homology domain. 
They are expressed on the surface of monocytes, macrophages, 
dendritic cells and epithelial cells or in the cytoplasm of cells from 
different tissues. In humans, 10 TLRs have emerged to mediate 
the activation of innate effector cells. Some of the TLRs reside at 
the cell surface, and some of them are located in the endoplasmatic 
reticulum. TLR1, 2, 4, 5 and 6 are present on the cell membrane 
which recognize mainly microbial membrane components such as 
lipids, lipoproteins and proteins, whereas TLR3, 7, 8 and 9 appear 
to be confined to intracellular compartments where they recognize 
microbial nucleic acid. Each TLR has different ligand recognition 
and has a distinct function in terms of PAMP recognition and 
immune response (Table 1). 
TLR4 responds to bacterial lipopolysaccharide (LPS), an outer 
membrance component of Gram-negative bacteria. In addition to 
LPS, TLR4 is involved in  recognition of respiratory syncytial virus 
fusion proteins
17). TLR2 form a heterodimer with TLR1 or TLR6 
recognize various microbial components, such as peptidoglycans, 
lipoprotein, and lipoteichoic acid from Gram-positive bacteria. 
TLR5 is involved in the recognition of flagellin protein com-
ponent of bacterial flagella. TLR5 is expressed and functional to 
the basolateral site of the epithelial cell in intestine. TLR3, 7, 9 
recognize the genomic RNA of virus including respiratory syncytial 
virus. TLR3 triggers mainly antiviral immune responses
17). 
In newborn, basal expression of TLR, the accessory protein, and 
the adaptor protein are equivalent to adult level, but activation by 
the TLR appears to be reduced
18). This reduction is age dependent 
pattern. One study with monocytes from very low birth weight 
infant (VLBWI) found that decreased surface expression of 
TLR4, lower mRNA expression of TLR4 and reduced cytokine 
production after LPS stimulation in gestational age less than 30 
weeks
19). Thus, monocytes in premature infants can be considered 
phenotypically and functionally immature. The other characteristic 
is impaired TLR4-mediated signaling in LPS-exposed newborn 
monocytes. Recent study provided evidence that TLR4-mediated, 
NF-κ B dependent transcriptional activation of neonatal monocytes 
macrophages was depressed
20). As a consequence, the defects of 
TLR activity cause the susceptibility to infection in the neonatal 
period. 
TLR associated neonatal researches
So far, there are little human researches about association with 
neonatal diseases and TLRs. Most researches are animal based. 
Among them, the relation with TLRs and neonatal sepsis is most 
advanced part
21-23). TLR2 and TLR4 expression is enhanced in 
preterm delivery with chorioamnionitis, and recent studies showed 
an association between preterm birth and TLR polymorphisms
24).
Recent study showed polymorphisms in TLR2, TLR5, IL10, and 
PLA2G2A genes were associated with preterm sepsis
25). 
The direct role of TLRs in neonatal brain injury is suspected
26, 
27). The strong innate immune response in the central nervous 
system (CNS) is critical for pathogen elimination and vital to host 
survival. However, it is evident that chronic or acute dysregulated 
inflammation in the CNS can cause tissue damage and neuro  de-
generation. Animal studies described a relation between the TLR4 
agonist LPS and brain injury in newborn animals
28). In necrotizing 
enterocolitis (NEC), increased proinflammatory cytokines are 
found in intestinal samples, suggesting that these mediators play a 
role in NEC development. One study in a rat NEC model showed 
overexpression of TLR2, as well as NFκ B in intestinal epithelial 
cells that was correlated with the severity of mucosal damage
29,30).
Also, the intestinal expression of TLRs and cytokines precedes 
histological injury in the experimental NEC
31). NEC is also 
associated with increased expression of TLR4 in the intestinal 
mucosa and physiological stressors such as exposure to LPS and 
hypoxia. These findings demonstrate a critical role for TLR4 in 
the development of NEC through effects on enterocyte injury and 
repair
32).
Table 1. Ligands for Various Toll Like Receptors in Human
Toll like receptor (TLR) Ligands
TLR1 (with TLR2)
TLR2
TLR3                    
TLR4                        
TLR5                       
TLR6 
TLR7                        
TLR8                        
TLR9                        
TLR10                       
Triacyllipopeptides (bacteria)
Peptidoglycan (bacteria)
Lipoteichoic acid
Diacyllipopeptides (mycoplasma)
Zymosan (fungi)
Atypical lipopolysaccharide (bacteria)
Lipoprotein
HSP70
Double-stranded RNA (virus)
Lipopolysaccharide (bacteria)
HSP60 (chlamydia)
F protein (respiratory syncytial virus)
Flagellin (bacteria)
Diacyllipopeptides (mycoplasma)
Single-stranded RNA (virus)
Single-stranded RNA (virus)
CpGDNA (bacteria, virus)
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Conclusion
The innate immune system in neonate is immature which results 
in increased susceptibility to various infections. On the other hand, 
newborn innate immunity has a characteristic feature that the 
balance of Th1 and Th2 type immunity and impairment of TLRs 
signaling downstream pathway. However, the functional state of 
the various components of innate immunity in newborn largely 
unknown and only recently a number of studies have assessed this 
feature of the innate immune system. Thus, more researches need 
to include the discovery of neonatal immune mechanism so that 
prevention and treatment of neonatal infections can more safely be 
targeted. 
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